Pediatrix Medical Group, Inc. MD
31.84 USD -0.96 (-2.93%)
At closeNov 5, 2026, 5:35 PM EST
31.72 -0.12 -0.38%
After hours · Nov 5, 5:35 PM ET
31.50 Day range 33.74
17.23 52-week range 33.74
- YTD
- +48.85%
- 1 year
- +46.80%
News
benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $28 to $31.
marketbeat.com What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call Pediatrix Medical Group NYSE: MD reported third-quarter 2026 adjusted EBITDA of $85 million, with management saying results exceeded its expectations despite rising costs across healthcare delivery.…
seekingalpha.com Pediatrix Medical Group, Inc. (MD) Q3 2026 Earnings Call Transcript Pediatrix Medical Group, Inc. ( MD ) Q3 2026 Earnings Call October 29, 2026 9:00 AM EDT Company Participants David Haddock - Executive Vice President, General Counsel & Secretary Mark Ordan - CEO &…
benzinga.com Pediatrix Medical Group Q3 2026 Earnings Call Transcript Pediatrix Medical Group (NYSE:MD) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
zacks.com Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates Pediatrix Medical Group (MD) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.67 per share a year ago.
benzinga.com Pediatrix Medical Group Q3 Adj. EPS $0.72 Beats $0.65 Estimate, Sales $501.374M Beat $498.144M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.65 by 10.77 percent. This is a 7.46 percent increase over earnings of…
businesswire.com Pediatrix Medical Group Reports Third Quarter Results FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results.
businesswire.com Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026 FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026.
zacks.com Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
businesswire.com HB Wealth Expands Into Texas With Experienced Three-Advisor Team ATLANTA--(BUSINESS WIRE)--HB Wealth, one of the nation's largest independent, fee-only registered investment advisers, today announced that Steven D. Podnos, MD, MBA, CFP®, Rachel Podnos O'Leary, JD,…
zacks.com Can Pediatrix Sustain Growth Despite Lower Patient Volumes? MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.
defenseworld.net Engineers Gate Manager LP Lowers Stock Position in Pediatrix Medical Group, Inc. $MD Engineers Gate Manager LP trimmed its holdings in Pediatrix Medical Group, Inc. (NYSE: MD) by 60.9% during the second quarter, according to its most recent filing with the Securities and Exchange…
zacks.com Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
defenseworld.net Sinopharm Group (OTCMKTS:SHTDY) and Pediatrix Medical Group (NYSE:MD) Financial Survey Sinopharm Group (OTCMKTS:SHTDY - Get Free Report) and Pediatrix Medical Group (NYSE: MD - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two…
zacks.com Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue? Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
zacks.com Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy? The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
gurufocus.com TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis (EoE) showed that AstraZeneca and Amgen's TEZSPIREÂ (te
zacks.com Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
benzinga.com This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday Wall Street analysts change outlook on top stocks, including BIDU and BMO. See their ratings and price targets on Benzinga's analyst page.- benzinga.com Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28 Jefferies analyst Jack Slevin downgrades Pediatrix Medical Group (NYSE:MD) from Buy to Hold and raises the price target from $27 to $28.
zacks.com Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.
zacks.com Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $25 to $28.
zacks.com Pediatrix Medical Tops Q2 Earnings on Better Cash Collections MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.
marketbeat.com Pediatrix Medical Group Q2 Earnings Call Highlights Pediatrix Medical Group NYSE: MD reported second-quarter 2026 adjusted EBITDA of $76 million and reaffirmed its full-year adjusted EBITDA outlook of $280 million to $300 million, as stronger…
seekingalpha.com Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
benzinga.com Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings…
benzinga.com Pediatrix Medical Group Q2 Adj. EPS $0.63 Beats $0.59 Estimate, Sales $487.783M Beat $478.449M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.59 by 6.78 percent. This is a 18.87 percent increase over earnings of…- benzinga.com Pediatrix Reports Q2 Payor Mix Remains Stable, No Material Changes In Net Revenue Trends; Reaffirms FY26 Adj EBITDA Outlook Of $280M-$300M Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today provided an update on its second quarter 2026 business trends.In response to…
benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $23 to $28.
benzinga.com Under the Radar: 5 Small-Cap Stocks Wall Street Is Missing One of the biggest mistakes investors make is spending all their time looking for what is cheap and almost no time looking for what is working. Do not get me wrong. I love cheap stocks. Anyone who…
benzinga.com Pediatrix Medical Group Publishes New Research On Probiotic Use And Necrotizing Enterocolitis In Preterm Infants Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced the publication of new research on probiotic use and necrotizing enterocolitis (NEC) in preterm…
benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $25 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $22 to $25.
benzinga.com Transcript: Pediatrix Medical Group Q1 2026 Earnings Conference Call 
benzinga.com Earnings Scheduled For May 5, 2026 - benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $23 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $21 to $23.
benzinga.com Mach Natural Resources, Mesoblast And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares dip 7.6% in pre-market trading.- benzinga.com Pediatrix Medical Group Expands Tennessee Footprint Through Collaboration With Tennessee Maternal-Fetal Medicine Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced its expansion in Middle Tennessee through a partnership with Tennessee Maternal-Fetal Medicine,…
- benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Lowers Price Target to $22 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $23 to $22.
benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Lowers Price Target to $21 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price target from $24 to $21.- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com Earnings Scheduled For February 19, 2026
- benzinga.com Pediatrix Medical Group Q4 Adj. EPS $0.50 Misses $0.54 Estimate, Sales $493.771M Beat $486.228M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.54 by 7.24 percent. This is a 1.96 percent decrease over earnings of…
benzinga.com Earnings Outlook For Pediatrix Medical Group - benzinga.com Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $24 Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price target from $17 to $24.
- benzinga.com UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $23 UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $23.
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Earnings Scheduled For November 3, 2025 - benzinga.com Pediatrix Medical Group Q3 Adj. EPS $0.67 Beats $0.47 Estimate, Sales $492.875M Beat $476.493M Estimate Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.47 by 43.78 percent. This is a 52.27 percent increase over earnings of…